Market Cap

Celyad Oncology SA Market Capitalization:

$14.2 Million

USD as of July 1, 2023

business Celyad Oncology SA Company Profile

Celyad Oncology SA Main Stock Listing

NASDAQ: CYAD

Market Capitalization History of Celyad Oncology SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Celyad Oncology SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 $53.5 M -44.73%
Jan. 1, 2022 $96.9 M -56.45%
Jan. 1, 2021 $222.5 M -25.37%
Jan. 1, 2020 $298.1 M -50.00%
Jan. 1, 2019 $596.2 M -53.92%
Jan. 1, 2018 $1.29 B 125.93%
Jan. 1, 2017 $572.7 M -40.90%
Jan. 1, 2016 $969.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Celyad Oncology SA Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

Celyad Oncology SA has the following listings and related stock indices.


Stock: NASDAQ: CYAD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.